カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

ヒトα1-プロテイナーゼ阻害剤の世界市場2025年：0.5g、1g

■ 英語タイトル：Global Human Alpha1-Proteinase Inhibitor Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3826）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3826
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥504,600見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥756,900見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,009,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒトα1-プロテイナーゼ阻害剤の世界市場2025年：0.5g、1g]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界のヒトα1-プロテイナーゼ阻害剤市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のヒトα1-プロテイナーゼ阻害剤の市場規模は2024年のxxx米ドルから2031年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ヒトα1-プロテイナーゼ阻害剤市場はタイプとアプリケーションによって区分されます。2020年～2031年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・0.5g、1g

アプリケーション別セグメントは次のように区分されます。
・病院、薬局

世界のヒトα1-プロテイナーゼ阻害剤市場の主要な市場プレーヤーは以下のとおりです。
・Takeda、Kamada、Talecris Biotherapeutics、CSL Behring

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、ヒトα1-プロテイナーゼ阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒトα1-プロテイナーゼ阻害剤メーカーの企業概要、2022年～2024年までのヒトα1-プロテイナーゼ阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒトα1-プロテイナーゼ阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2020年～2031年までの地域別ヒトα1-プロテイナーゼ阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2020年～2031年までのヒトα1-プロテイナーゼ阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2020年～2024年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒトα1-プロテイナーゼ阻害剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヒトα1-プロテイナーゼ阻害剤の産業チェーンを掲載しています。
・第13、14、15章では、ヒトα1-プロテイナーゼ阻害剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– ヒトα1-プロテイナーゼ阻害剤の概要
– 種類別分析（2020年vs2024年vs2031年）：0.5g、1g
– 用途別分析（2020年vs2024年vs2031年）：病院、薬局
– 世界のヒトα1-プロテイナーゼ阻害剤市場規模・予測
– 世界のヒトα1-プロテイナーゼ阻害剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Takeda、Kamada、Talecris Biotherapeutics、CSL Behring
・メーカー別市場シェア・市場集中度
・地域別市場分析2020年-2031年
・種類別分析2020年-2031年：0.5g、1g
・用途別分析2020年-2031年：病院、薬局
・ヒトα1-プロテイナーゼ阻害剤の北米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒトα1-プロテイナーゼ阻害剤のヨーロッパ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒトα1-プロテイナーゼ阻害剤のアジア市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒトα1-プロテイナーゼ阻害剤の南米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒトα1-プロテイナーゼ阻害剤の中東・アフリカ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Alpha1-Proteinase Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Alpha1-Proteinase Inhibitor Revenue by Type: 2020 Versus 2024 Versus 2031
1.2.2 0.5g
1.2.3 1g
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Alpha1-Proteinase Inhibitor Revenue by Application: 2020 Versus 2024 Versus 2031
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Human Alpha1-Proteinase Inhibitor Market Size & Forecast
1.4.1 Global Human Alpha1-Proteinase Inhibitor Sales in Value (2020 & 2024 & 2031)
1.4.2 Global Human Alpha1-Proteinase Inhibitor Sales in Volume (2020-2031)
1.4.3 Global Human Alpha1-Proteinase Inhibitor Price (2020-2031)
1.5 Global Human Alpha1-Proteinase Inhibitor Production Capacity Analysis
1.5.1 Global Human Alpha1-Proteinase Inhibitor Total Production Capacity (2020-2031)
1.5.2 Global Human Alpha1-Proteinase Inhibitor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Alpha1-Proteinase Inhibitor Market Drivers
1.6.2 Human Alpha1-Proteinase Inhibitor Market Restraints
1.6.3 Human Alpha1-Proteinase Inhibitor Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Human Alpha1-Proteinase Inhibitor Product and Services
2.1.4 Takeda Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.2 Kamada
2.2.1 Kamada Details
2.2.2 Kamada Major Business
2.2.3 Kamada Human Alpha1-Proteinase Inhibitor Product and Services
2.2.4 Kamada Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.3 Talecris Biotherapeutics
2.3.1 Talecris Biotherapeutics Details
2.3.2 Talecris Biotherapeutics Major Business
2.3.3 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product and Services
2.3.4 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.4 CSL Behring
2.4.1 CSL Behring Details
2.4.2 CSL Behring Major Business
2.4.3 CSL Behring Human Alpha1-Proteinase Inhibitor Product and Services
2.4.4 CSL Behring Human Alpha1-Proteinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
3 Human Alpha1-Proteinase Inhibitor Breakdown Data by Manufacturer
3.1 Global Human Alpha1-Proteinase Inhibitor Sales in Volume by Manufacturer (2021, 2022, 2023, and 2024)
3.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturer (2021, 2022, 2023, and 2024)
3.3 Key Manufacturer Market Position in Human Alpha1-Proteinase Inhibitor
3.4 Market Concentration Rate
3.4.1 Top 3 Human Alpha1-Proteinase Inhibitor Manufacturer Market Share in 2024
3.4.2 Top 6 Human Alpha1-Proteinase Inhibitor Manufacturer Market Share in 2024
3.5 Global Human Alpha1-Proteinase Inhibitor Production Capacity by Company: 2023 VS 2024
3.6 Manufacturer by Geography: Head Office and Human Alpha1-Proteinase Inhibitor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Alpha1-Proteinase Inhibitor Market Size by Region
4.1.1 Global Human Alpha1-Proteinase Inhibitor Sales in Volume by Region (2020-2031)
4.1.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2020-2031)
4.2 North America Human Alpha1-Proteinase Inhibitor Revenue (2020-2031)
4.3 Europe Human Alpha1-Proteinase Inhibitor Revenue (2020-2031)
4.4 Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue (2020-2031)
4.5 South America Human Alpha1-Proteinase Inhibitor Revenue (2020-2031)
4.6 Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue (2020-2031)
5 Market Segment by Type
5.1 Global Human Alpha1-Proteinase Inhibitor Sales in Volume by Type (2020-2031)
5.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2020-2031)
5.3 Global Human Alpha1-Proteinase Inhibitor Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Human Alpha1-Proteinase Inhibitor Sales in Volume by Application (2020-2031)
6.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2020-2031)
6.3 Global Human Alpha1-Proteinase Inhibitor Price by Application (2020-2031)
7 North America by Country, by Type, and by Application
7.1 North America Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2031)
7.2 North America Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2031)
7.3 North America Human Alpha1-Proteinase Inhibitor Market Size by Country
7.3.1 North America Human Alpha1-Proteinase Inhibitor Sales in Volume by Country (2020-2031)
7.3.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2031)
8.2 Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2031)
8.3 Europe Human Alpha1-Proteinase Inhibitor Market Size by Country
8.3.1 Europe Human Alpha1-Proteinase Inhibitor Sales in Volume by Country (2020-2031)
8.3.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2031)
9.2 Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2031)
9.3 Asia-Pacific Human Alpha1-Proteinase Inhibitor Market Size by Region
9.3.1 Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales in Volume by Region (2020-2031)
9.3.2 Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America by Region, by Type, and by Application
10.1 South America Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2031)
10.2 South America Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2031)
10.3 South America Human Alpha1-Proteinase Inhibitor Market Size by Country
10.3.1 South America Human Alpha1-Proteinase Inhibitor Sales in Volume by Country (2020-2031)
10.3.2 South America Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2031)
11.2 Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2031)
11.3 Middle East & Africa Human Alpha1-Proteinase Inhibitor Market Size by Country
11.3.1 Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales in Volume by Country (2020-2031)
11.3.2 Middle East & Africa Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Alpha1-Proteinase Inhibitor and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Alpha1-Proteinase Inhibitor
12.3 Human Alpha1-Proteinase Inhibitor Production Process
12.4 Human Alpha1-Proteinase Inhibitor Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Alpha1-Proteinase Inhibitor Typical Distributors
13.3 Human Alpha1-Proteinase Inhibitor Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Alpha1-Proteinase Inhibitor Revenue by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Alpha1-Proteinase Inhibitor Revenue by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Human Alpha1-Proteinase Inhibitor Product and Services
Table 6. Takeda Human Alpha1-Proteinase Inhibitor Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 7. Kamada Basic Information, Manufacturing Base and Competitors
Table 8. Kamada Major Business
Table 9. Kamada Human Alpha1-Proteinase Inhibitor Product and Services
Table 10. Kamada Human Alpha1-Proteinase Inhibitor Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 11. Talecris Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 12. Talecris Biotherapeutics Major Business
Table 13. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product and Services
Table 14. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 15. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 16. CSL Behring Major Business
Table 17. CSL Behring Human Alpha1-Proteinase Inhibitor Product and Services
Table 18. CSL Behring Human Alpha1-Proteinase Inhibitor Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 19. Global Human Alpha1-Proteinase Inhibitor Sales by Manufacturer (2021, 2022, 2023, and 2024) & (MT)
Table 20. Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturer (2021, 2022, 2023, and 2024) & (USD Million)
Table 21. Market Position of Manufacturers in Human Alpha1-Proteinase Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 22. Global Human Alpha1-Proteinase Inhibitor Production Capacity by Company, (MT): 2023 VS 2024
Table 23. Head Office and Human Alpha1-Proteinase Inhibitor Production Site of Key Manufacturer
Table 24. Human Alpha1-Proteinase Inhibitor New Entrant and Capacity Expansion Plans
Table 25. Human Alpha1-Proteinase Inhibitor Mergers & Acquisitions in the Past Five Years
Table 26. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2020-2024) & (MT)
Table 27. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2025-2031) & (MT)
Table 28. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2020-2024) & (USD Million)
Table 29. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2025-2031) & (USD Million)
Table 30. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2024) & (MT)
Table 31. Global Human Alpha1-Proteinase Inhibitor Sales by Type (2025-2031) & (MT)
Table 32. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2020-2024) & (USD Million)
Table 33. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2025-2031) & (USD Million)
Table 34. Global Human Alpha1-Proteinase Inhibitor Price by Type (2020-2024) & (USD/Kg)
Table 35. Global Human Alpha1-Proteinase Inhibitor Price by Type (2025-2031) & (USD/Kg)
Table 36. Global Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2024) & (MT)
Table 37. Global Human Alpha1-Proteinase Inhibitor Sales by Application (2025-2031) & (MT)
Table 38. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2020-2024) & (USD Million)
Table 39. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2025-2031) & (USD Million)
Table 40. Global Human Alpha1-Proteinase Inhibitor Price by Application (2020-2024) & (USD/Kg)
Table 41. Global Human Alpha1-Proteinase Inhibitor Price by Application (2025-2031) & (USD/Kg)
Table 42. North America Human Alpha1-Proteinase Inhibitor Sales by Country (2020-2024) & (MT)
Table 43. North America Human Alpha1-Proteinase Inhibitor Sales by Country (2025-2031) & (MT)
Table 44. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2024) & (USD Million)
Table 45. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2025-2031) & (USD Million)
Table 46. North America Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2024) & (MT)
Table 47. North America Human Alpha1-Proteinase Inhibitor Sales by Type (2025-2031) & (MT)
Table 48. North America Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2024) & (MT)
Table 49. North America Human Alpha1-Proteinase Inhibitor Sales by Application (2025-2031) & (MT)
Table 50. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2020-2024) & (MT)
Table 51. Europe Human Alpha1-Proteinase Inhibitor Sales by Country (2025-2031) & (MT)
Table 52. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2024) & (USD Million)
Table 53. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2025-2031) & (USD Million)
Table 54. Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2024) & (MT)
Table 55. Europe Human Alpha1-Proteinase Inhibitor Sales by Type (2025-2031) & (MT)
Table 56. Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2024) & (MT)
Table 57. Europe Human Alpha1-Proteinase Inhibitor Sales by Application (2025-2031) & (MT)
Table 58. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Region (2020-2024) & (MT)
Table 59. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Region (2025-2031) & (MT)
Table 60. Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2020-2024) & (USD Million)
Table 61. Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region (2025-2031) & (USD Million)
Table 62. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2024) & (MT)
Table 63. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Type (2025-2031) & (MT)
Table 64. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2024) & (MT)
Table 65. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales by Application (2025-2031) & (MT)
Table 66. South America Human Alpha1-Proteinase Inhibitor Sales by Country (2020-2024) & (MT)
Table 67. South America Human Alpha1-Proteinase Inhibitor Sales by Country (2025-2031) & (MT)
Table 68. South America Human Alpha1-Proteinase Inhibitor Revenue by Country (2020-2024) & (USD Million)
Table 69. South America Human Alpha1-Proteinase Inhibitor Revenue by Country (2025-2031) & (USD Million)
Table 70. South America Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2024) & (MT)
Table 71. South America Human Alpha1-Proteinase Inhibitor Sales by Type (2025-2031) & (MT)
Table 72. South America Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2024) & (MT)
Table 73. South America Human Alpha1-Proteinase Inhibitor Sales by Application (2025-2031) & (MT)
Table 74. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Region (2020-2024) & (MT)
Table 75. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Region (2025-2031) & (MT)
Table 76. Middle East & Africa Human Alpha1-Proteinase Inhibitor Revenue by Region (2020-2024) & (USD Million)
Table 77. Middle East & Africa Human Alpha1-Proteinase Inhibitor Revenue by Region (2025-2031) & (USD Million)
Table 78. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Type (2020-2024) & (MT)
Table 79. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Type (2025-2031) & (MT)
Table 80. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Application (2020-2024) & (MT)
Table 81. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales by Application (2025-2031) & (MT)
Table 82. Human Alpha1-Proteinase Inhibitor Raw Material
Table 83. Key Manufacturers of Human Alpha1-Proteinase Inhibitor Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Human Alpha1-Proteinase Inhibitor Typical Distributors
Table 87. Human Alpha1-Proteinase Inhibitor Typical Customers
List of Figures
Figure 1. Human Alpha1-Proteinase Inhibitor Picture
Figure 2. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type in 2024
Figure 3. 0.5g
Figure 4. 1g
Figure 5. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application in 2024
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Human Alpha1-Proteinase Inhibitor Revenue, (USD Million) & (MT): 2020 & 2024 & 2031
Figure 9. Global Human Alpha1-Proteinase Inhibitor Revenue and Forecast (2020-2031) & (USD Million)
Figure 10. Global Human Alpha1-Proteinase Inhibitor Sales (2020-2031) & (MT)
Figure 11. Global Human Alpha1-Proteinase Inhibitor Price (2020-2031) & (USD/Kg)
Figure 12. Global Human Alpha1-Proteinase Inhibitor Production Capacity (2020-2031) & (MT)
Figure 13. Global Human Alpha1-Proteinase Inhibitor Production Capacity by Geographic Region: 2024 VS 2031
Figure 14. Human Alpha1-Proteinase Inhibitor Market Drivers
Figure 15. Human Alpha1-Proteinase Inhibitor Market Restraints
Figure 16. Human Alpha1-Proteinase Inhibitor Market Trends
Figure 17. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturer in 2024
Figure 18. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Manufacturer in 2024
Figure 19. Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 20. Top 3 Human Alpha1-Proteinase Inhibitor Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Human Alpha1-Proteinase Inhibitor Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2020-2031)
Figure 23. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2020-2031)
Figure 24. North America Human Alpha1-Proteinase Inhibitor Revenue (2020-2031) & (USD Million)
Figure 25. Europe Human Alpha1-Proteinase Inhibitor Revenue (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue (2020-2031) & (USD Million)
Figure 27. South America Human Alpha1-Proteinase Inhibitor Revenue (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Human Alpha1-Proteinase Inhibitor Revenue (2020-2031) & (USD Million)
Figure 29. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2031)
Figure 30. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2020-2031)
Figure 31. Global Human Alpha1-Proteinase Inhibitor Price by Type (2020-2031) & (USD/Kg)
Figure 32. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
Figure 33. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2020-2031)
Figure 34. Global Human Alpha1-Proteinase Inhibitor Price by Application (2020-2031) & (USD/Kg)
Figure 35. North America Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2031)
Figure 36. North America Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
Figure 37. North America Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
Figure 38. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
Figure 39. United States Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 40. Canada Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 41. Mexico Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 42. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2031)
Figure 43. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
Figure 44. Europe Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
Figure 45. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
Figure 46. Germany Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 47. France Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 48. United Kingdom Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 49. Russia Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 50. Italy Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2020-2031)
Figure 55. China Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 56. Japan Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 57. Korea Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 58. India Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 59. Southeast Asia Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 60. Australia Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 61. South America Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2031)
Figure 62. South America Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
Figure 63. South America Human Alpha1-Proteinase Inhibitor Sales Market Share by Country (2020-2031)
Figure 64. South America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Country (2020-2031)
Figure 65. Brazil Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 66. Argentina Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2020-2031)
Figure 70. Middle East & Africa Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2020-2031)
Figure 71. Turkey Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 72. Egypt Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 74. South Africa Human Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Human Alpha1-Proteinase Inhibitor in 2024
Figure 76. Manufacturing Process Analysis of Human Alpha1-Proteinase Inhibitor
Figure 77. Human Alpha1-Proteinase Inhibitor Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒトα1-プロテイナーゼ阻害剤市場：グローバル予測2024年-2030年
  • C1エステラーゼインヒビターの世界市場2025年：ヒト、組換え体
  • 抗阻害剤凝固剤複合体の世界市場2025年：50ML、20ML
  • 染料用移染防止剤：グローバル市場シェア・需要予測2024-2030
  • ミドスタウリンの世界市場2025年：AML、MDS、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3826 )"ヒトα1-プロテイナーゼ阻害剤の世界市場2025年：0.5g、1g" (英文：Global Human Alpha1-Proteinase Inhibitor Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。